"Dideoxynucleotides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The phosphate esters of DIDEOXYNUCLEOSIDES.
| Descriptor ID |
D054306
|
| MeSH Number(s) |
D13.695.225
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dideoxynucleotides".
Below are MeSH descriptors whose meaning is more specific than "Dideoxynucleotides".
This graph shows the total number of publications written about "Dideoxynucleotides" by people in this website by year, and whether "Dideoxynucleotides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dideoxynucleotides" by people in Profiles.
-
Nucleotide analogues as inhibitors of SARS-CoV Polymerase. Pharmacol Res Perspect. 2020 12; 8(6):e00674.
-
A CRISPR/Cas9 approach reveals that the polymerase activity of DNA polymerase ß is dispensable for HIV-1 infection in dividing and nondividing cells. J Biol Chem. 2017 08 25; 292(34):14016-14025.
-
Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear Cells. Antimicrob Agents Chemother. 2015 Oct; 59(10):6395-401.
-
SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother. 2014 Aug; 58(8):4915-9.
-
The Y181C substitution in 3'-azido-3'-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer. J Biol Chem. 2003 Oct 17; 278(42):40464-72.